Dr. Martin Mengel is an independent consultant in vaccinology and life sciences with a special focus on emerging markets. He helps companies from the vaccines and pharma industries and international agencies in the development of their business strategy and product portfolio. He also develops innovative mobile health solutions including diagnostics, for developing countries.
Prior to this he served as director of the African Network on Diarrhoeal Diseases Surveillance and Cholera vaccine introduction (www.africhol.org) working with over 150 collaborators in 11 sub-Saharan countries. Dr Mengel chaired the working group for cholera epidemiology at the World Health Organization for four years. He also led the WHO- Collaborating Centre for evidence based vaccinology and was director of the initiative on “Supporting National Independent Immunization and Advisory Committees (SIVAC)” and leader of the enteric diseases program at Agence de Médecine Préventive in Paris.
Dr Mengel completed the European Program for Intervention Epidemiology Training with the European Centre for Disease Prevention and Control in Stockholm, Sweden and the National Center for Epidemiology, Madrid, Spain. He has worked on various public health projects worldwide including trans-national outbreak investigations, surveillance (H1N1, HIV-AIDS, food-borne disease), epidemic intelligence, and academic teaching. Before that, he worked as a paediatrician at the University Children’s Clinic of Cologne. He has co-authored over 30 peer-reviewed publications primarily on infectious diseases and public-health with a focus on Africa. He holds an MSc in tropical diseases from the University of Valencia, Spain, an MD from the University of Bonn, Germany, a MSc in field epidemiology from the National School of Health in Madrid, Spain and is a visiting professor at the Universities of Maastricht and Tilburg in the Netherlands.